WallStSmart

Calumet Specialty Products Partners (CLMT)vsEcolab Inc (ECL)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Ecolab Inc generates 267% more annual revenue ($16.84B vs $4.59B). ECL leads profitability with a 12.6% profit margin vs -3.0%. CLMT appears more attractively valued with a PEG of 0.65. CLMT earns a higher WallStSmart Score of 54/100 (C-).

CLMT

Buy

54

out of 100

Grade: C-

Growth: 7.3Profit: 2.0Value: 6.0Quality: 5.0
Piotroski: 5/9Altman Z: 0.84

ECL

Buy

53

out of 100

Grade: C-

Growth: 4.7Profit: 7.0Value: 3.7Quality: 5.5
Piotroski: 3/9Altman Z: 2.17

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CLMT4 strengths · Avg: 9.5/10
Revenue GrowthGrowth
40.8%10/10

Revenue surging 40.8% year-over-year

EPS GrowthGrowth
562.0%10/10

Earnings expanding 562.0% YoY

Debt/EquityHealth
-1.9910/10

Conservative balance sheet, low leverage

PEG RatioValuation
0.658/10

Growing faster than its price suggests

ECL2 strengths · Avg: 9.0/10
Market CapQuality
$80.38B9/10

Large-cap with strong market position

Return on EquityProfitability
21.1%9/10

Every $100 of equity generates 21 in profit

Areas to Watch

CLMT4 concerns · Avg: 1.5/10
Return on EquityProfitability
-1172.0%2/10

ROE of -1172.0% — below average capital efficiency

Altman Z-ScoreHealth
0.842/10

Distress zone — elevated risk

Profit MarginProfitability
-3.0%1/10

Currently unprofitable

Operating MarginProfitability
-4.6%1/10

Operating margin of -4.6%

ECL4 concerns · Avg: 3.5/10
P/E RatioValuation
38.3x4/10

Premium valuation, high expectations priced in

EPS GrowthGrowth
3.3%4/10

3.3% earnings growth

Debt/EquityHealth
1.373/10

Elevated debt levels

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Comparative Analysis Report

WallStSmart Research

Bull Case : CLMT

The strongest argument for CLMT centers on Revenue Growth, EPS Growth, Debt/Equity. Revenue growth of 40.8% demonstrates continued momentum. PEG of 0.65 suggests the stock is reasonably priced for its growth.

Bull Case : ECL

The strongest argument for ECL centers on Market Cap, Return on Equity.

Bear Case : CLMT

The primary concerns for CLMT are Return on Equity, Altman Z-Score, Profit Margin.

Bear Case : ECL

The primary concerns for ECL are P/E Ratio, EPS Growth, Debt/Equity.

Key Dynamics to Monitor

CLMT profiles as a hypergrowth stock while ECL is a value play — different risk/reward profiles.

ECL carries more volatility with a beta of 0.89 — expect wider price swings.

CLMT is growing revenue faster at 40.8% — sustainability is the question.

ECL generates stronger free cash flow (489M), providing more financial flexibility.

Bottom Line

CLMT scores higher overall (54/100 vs 53/100) and 40.8% revenue growth. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Calumet Specialty Products Partners

BASIC MATERIALS · SPECIALTY CHEMICALS · USA

Calumet Specialty Products Partners, LP produces and sells specialty hydrocarbon products in North America and internationally. The company is headquartered in Indianapolis, Indiana.

Ecolab Inc

BASIC MATERIALS · SPECIALTY CHEMICALS · USA

Ecolab Inc., headquartered in St. Paul, Minnesota, is an American corporation that develops and offers services, technology and systems that specialize in water treatment, purification, cleaning and hygiene in a wide variety of applications. It helps organizations both private market as well as public treat their water, not only for drinking directly, but also for use in food, healthcare, hospitality related safety and industry.

Want to dig deeper into these stocks?